Philip Morris International Inc. (PM)
Philip Morris (PM) is a Great Momentum Stock: Should You Buy?
Does Philip Morris (PM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Philip Morris Beats Expectations in Q2: ETFs in Focus
Look at ETFs with exposure to Philip Morris, as the tobacco giant reports second-quarter earnings.
Philip Morris: 5% Yield Is Now Too Expensive (Rating Downgrade)
Philip Morris International beat Q2 earnings estimates, driven by growth in smoke-free products like IQOS and ZYN. The company's strong performance led to a 9.6% net revenue growth rate and a 12.5% operating income increase year over year. Philip Morris also raised its EPS growth outlook for FY 2024.
Looking for a Growth Stock? 3 Reasons Why Philip Morris (PM) is a Solid Choice
Philip Morris (PM) possesses solid growth attributes, which could help it handily outperform the market.
Philip Morris International: Time to Buy the Ultimate Dividend Growth Stock?
Philip Morris International is up 20% year to date on continued strong growth. It has stable cigarette volumes and a fast-growing smoke-free products business.
Huge News For Philip Morris International Stock: Here's What Comes Next
Philip Morris stock is up due to strong volume gains at its new nicotine pouch business and healthy profit growth. The company has a stable international cigarette business.
Philip Morris International Just Raised Guidance Again. Is Now a Great Opportunity to Buy the Stock?
Philip Morris International posted strong Q2 results and once again upped its full-year guidance. Zyn continues to be the big growth driver for the company.
Philip Morris: Double-Digit Upside Still Possible - Thanks To Robust Tobacco Monetization
PM continues to demonstrate why it is the best of breed tobacco stock, thanks to its growing combustible sales volume and the Smoke-Free approaches already accretive to its top/ bottom-lines. Our previous ZYN thesis has also played out as expected, attributed to the double digit YoY growth in its nicotine pouch sale volume globally in FQ2'24. With the management already guiding higher US nicotine pouch sales volume and capex in 2024, ZYN may remain a growth driver moving forward, thanks to the Swedish Match acquisition.
Philip Morris: Strong Sales, Lower Health Risks From Smokeless Products
Philip Morris is shifting towards smoke-free products to reduce harm caused by smoking, aiming for smokeless products to generate over two-thirds of total net revenues by 2030. Strong performance in 2Q with increased demand for Zyn nicotine pouches led to a raised forecast for net income growth. Despite the controversial past, Philip Morris' shares continue to be a strong buy, with impressive revenue growth and transition towards smoke-free products showing promising results.
Philip Morris's Latest Earnings Call Is Boosting the Stock, but Do Tobacco Products Have Long-Term Staying Power?
Management reported a strong Q2 with solid performance from core tobacco and impressive growth from smokeless products. The cigarette business remains in a long-term downtrend.
Philip Morris Gains on Earnings Beat, Raised Outlook
Philip Morris International (PM) shares rose Tuesday to their highest level in more than two years after the tobacco giant posted better-than-expected results and raised its full-year outlook on growing demand for its smokeless products.
Philip Morris (PM) Ups View on Q2 Earnings Beat: Pricing Aids
Philip Morris' (PM) second-quarter 2024 results reflect continued strength in pricing and the company's smoke-free business. Management raises guidance despite adverse currency fluctuations.
